Showing results (181-190 of 201) with videos related to
Sort By:
Pageof 21
Journal of Adolescent and Young Adult Oncology|September 13, 2021
Identified Enrollment Challenges of Adolescent and Young Adult Patients on the Nonchemotherapy Arm of Children's Oncology Group Study ARST1321Viswatej Avutu, Aaron R Weiss, Damon R Reed, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 5, 2020
Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to PembrolizumabEmily Z Keung, Melissa Burgess, Ruth Salazar, et al.The Lancet. Oncology|October 10, 2017
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trialHussein A Tawbi, Melissa Burgess, Vanessa Bolejack, et al.Head & Neck|April 7, 2026
Colocated Multidisciplinary Clinic Is Associated With Improved Timeliness to Postoperative Adjuvant Therapy in Head and Neck Cancer PatientsGeorges E Daoud, Melissa F Riedel, Martha J Ryan, et al.The New England Journal of Medicine|December 22, 2018
Sorafenib for Advanced and Refractory Desmoid TumorsMrinal M Gounder, Michelle R Mahoney, Brian A Van Tine, et al.Science Translational Medicine|January 8, 2016
A mouse-human phase 1 co-clinical trial of a protease-activated fluorescent probe for imaging cancerMelodi Javid Whitley, Diana M Cardona, Alexander L Lazarides, et al.The Lancet. Oncology|June 28, 2017
Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trialWilliam D Tap, Zsuzsanna Papai, Brian A Van Tine, et al.Journal of the National Comprehensive Cancer Network : JNCCN|April 11, 2014
Soft tissue sarcoma, version 2.2014Margaret von Mehren, R Lor Randall, Robert S Benjamin, et al.Lancet (London, England)|November 15, 2024
Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC032): an open-label, randomised clinical trialYvonne M Mowery, Karla V Ballman, Angela M Hong, et al.Journal of the National Comprehensive Cancer Network : JNCCN|June 11, 2016
Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in OncologyMargaret von Mehren, R Lor Randall, Robert S Benjamin, et al.Pageof 21